CTI BioPharma
CTIC
#5896
Rank
HK$9.40 B
Marketcap
HK$71.28
Share price
0.00%
Change (1 day)
30.66%
Change (1 year)

CTI BioPharma (CTIC) - Total assets

Total assets on the balance sheet as of March 2023 : HK$0.88 Billion

According to CTI BioPharma 's latest financial reports the company's total assets are HK$0.88 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

CTI BioPharma - Total assets on balance sheet (from 2001 to 2023)

Total assets by year

Year Total assets Change
2022-12-31HK$0.98 B74.2%
2021-12-31HK$0.56 B25.1%
2020-12-31HK$0.45 B25.26%
2019-12-31HK$0.36 B-48.76%
2018-12-31HK$0.70 B64.05%
2017-12-31HK$0.42 B-13.38%
2016-12-31HK$0.49 B-55.74%
2015-12-31HK$1.11 B56.28%
2014-12-31HK$0.71 B-1.51%
2013-12-31HK$0.72 B27.2%
2012-12-31HK$0.57 B18.2%
2011-12-31HK$0.48 B15.91%
2010-12-31HK$0.41 B-22.71%
2009-12-31HK$0.53 B8.7%
2008-12-31HK$0.49 B-13.39%
2007-12-31HK$0.57 B-27.62%
2006-12-31HK$0.79 B-34.29%
2005-12-31HK$1.20 B-16.17%
2004-12-31HK$1.43 B26.96%
2003-12-31HK$1.13 B-22.26%
2002-12-31HK$1.45 B-38.5%
2001-12-31HK$2.36 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Novartis
NVS
HK$929.49 B 105,475.74%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
HK$914.15 B 103,733.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$725.38 B 82,292.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
HK$155.62 B 17,576.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Incyte
INCY
HK$57.55 B 6,436.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$678.11 B 76,923.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
HK$313.98 B 35,563.39%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel